UniProt Q51918
Protein L (Q51918)
Protein L (UniProt Q51918): 24 experimental structures on GenesisL1, 1 ligand bound, 23 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q51918
- Protein
- Protein L
- Experimental structures
- 24
- Predicted models
- 0
- Ligands
- 1
- Pockets
- 23 · 7 records with a druggable one
Structures
24 records of Q51918 in the MolNFT archive: 24 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1HEZ | Structure of P. magnus protein L bound to a human IgM Fab. | x-ray diffraction | E | — | — |
| 1HEZ | Structure of P. magnus protein L bound to a human IgM Fab. | x-ray diffraction | E | — | — |
| 1YMH | anti-HCV Fab 19D9D6 complexed with protein L (PpL) mutant A66W | x-ray diffraction | E, F | — | — |
| 1YMH | Anti-HCV Fab 19D9D6 complexed with protein L (ppl) mutant A66W | x-ray diffraction | E, F | — | — |
| 2FS1 | solution structure of PSD-1 | solution nmr | A | — | — |
| 2FS1 | Solution structure of psd-1 | solution nmr | A | — | — |
| 4IOI | Meditope-enabled trastuzumab in complex with CQFDLSTRRLKC | x-ray diffraction | E | — | — |
| 4IOI | Meditope-enabled trastuzumab in complex with cqfdlstrrlkc | x-ray diffraction | E | — | — |
| 5U3D | Structure of meditope enabled trastuzumab I83E variant | x-ray diffraction | E | — | 4 (best 0.66) |
| 5U3D | Structure of meditope enabled trastuzumab I83E variant | x-ray diffraction | E | — | — |
| 5U5F | MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK | x-ray diffraction | E | — | 4 (best 0.55) |
| 5U5F | Meditope enabled trastuzumab I83E variant in complex with (ac) CQFDA(PH)2STRRLRCGGSK | x-ray diffraction | E | — | — |
| 5U5M | Crystal structure of I83E meditope-enabled trastuzumab with azido-meditope | x-ray diffraction | E | — | — |
| 5U5M | Crystal structure of I83E meditope-enabled trastuzumab with azido- meditope | x-ray diffraction | E | ACE | — |
| 5U6A | Crystal structure of I83E meditope-enabled trastuzumab with azido-PEG3-meditope | x-ray diffraction | E | — | 4 (best 0.53) |
| 5U6A | Crystal structure of I83E meditope-enabled trastuzumab with azido- PEG3-meditope | x-ray diffraction | E | ACE | — |
| 6B9Y | Trastuzumab Fab v3 in complex with 5-phenyl meditope variant | x-ray diffraction | E | — | 2 (best 0.52) |
| 6B9Y | Trastuzumab Fab V3 in complex with 5-phenyl meditope variant | x-ray diffraction | E | — | — |
| 6B9Z | Trastuzumab Fab v3 | x-ray diffraction | E | — | 3 (best 0.65) |
| 6B9Z | Trastuzumab Fab V3 | x-ray diffraction | E | — | — |
| 6BAE | Trastuzumab Fab v3 in complex with CQFDLSTRRLKC | x-ray diffraction | E | — | 3 (best 0.52) |
| 6BAE | Trastuzumab Fab V3 in complex with cqfdlstrrlkc | x-ray diffraction | E | ACE | — |
| 6BAH | Trastuzumab Fab v3 with 5-diphenyl meditope variant | x-ray diffraction | E | — | 3 (best 0.55) |
| 6BAH | Trastuzumab Fab V3 with 5-diphenyl meditope variant | x-ray diffraction | E | ACE | — |
Ligands
- ACE · Acetyl group · in 4 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.